Cargando…
Viral Vector-Based Delivery of CRISPR/Cas9 and Donor DNA for Homology-Directed Repair in an In Vitro Model for Canine Hemophilia B
Gene therapy represents an attractive alternative to treat hemophilia B. Here we established three hepatocyte-derived cell lines based on Huh7, PLC/PRF/5, and Hep3B cells stably carrying a mutated canine FIX (cFIXmut) transgene containing a single point mutation in the catalytic domain. Based on the...
Autores principales: | Gao, Jian, Bergmann, Thorsten, Zhang, Wenli, Schiwon, Maren, Ehrke-Schulz, Eric, Ehrhardt, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356096/ https://www.ncbi.nlm.nih.gov/pubmed/30690229 http://dx.doi.org/10.1016/j.omtn.2018.12.008 |
Ejemplares similares
-
CRISPR/Cas9 delivery with one single adenoviral vector devoid of all viral genes
por: Ehrke-Schulz, Eric, et al.
Publicado: (2017) -
One-Vector System for Multiplexed CRISPR/Cas9 against Hepatitis B Virus cccDNA Utilizing High-Capacity Adenoviral Vectors
por: Schiwon, Maren, et al.
Publicado: (2018) -
Adenoviral Vectors Armed with PAPILLOMAVIRUs Oncogene Specific CRISPR/Cas9 Kill Human-Papillomavirus-Induced Cervical Cancer Cells
por: Ehrke-Schulz, Eric, et al.
Publicado: (2020) -
Quantification of designer nuclease induced mutation rates: a direct comparison of different methods
por: Ehrke-Schulz, Eric, et al.
Publicado: (2016) -
A Human In Vitro Model to Study Adenoviral Receptors and Virus Cell Interactions
por: Tsoukas, Raphael L., et al.
Publicado: (2022)